Neflumozide
Product Specifications
UNSPSC Description
Neflumozide (HRP 913) is an orally active benzisoxazole derivative and a potent dopamine antagonist with antipsychotic activity. Neflumozide can be utilized in psychosis research[1].
Target Antigen
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/neflumozide.html
Smiles
O=C1NC2=C(N1C3CCN(CC3)CCCC4=NOC5=C4C=CC(F)=C5)C=CC=C2
Molecular Weight
394.44
References & Citations
[1]Stuart F, et al. The preclinical antipsychotic evaluation of HRP 913, a novel benzisoxazole derivative, Drug Development Research, Volume3, Issue3, 1983, Pages 233-243
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-167875/Neflumozide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-167875/
Clinical Information
No Development Reported
CAS Number
86636-93-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal CD3 Antibody (17A2) [PE/Atto594]](https://cdn.genprice.uk/genprice/genprice5.png)
